Mauro Boiocchi

6.9k total citations
119 papers, 5.4k citations indexed

About

Mauro Boiocchi is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Mauro Boiocchi has authored 119 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Oncology, 51 papers in Pathology and Forensic Medicine and 43 papers in Molecular Biology. Recurrent topics in Mauro Boiocchi's work include Lymphoma Diagnosis and Treatment (32 papers), Viral-associated cancers and disorders (27 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Mauro Boiocchi is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Viral-associated cancers and disorders (27 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Mauro Boiocchi collaborates with scholars based in Italy, United States and Canada. Mauro Boiocchi's co-authors include Riccardo Dolcetti, Giuseppe Toffoli, Vallì De Re, Antonio Russo, Antonino Carbone, Claudio Doglioni, Annunziata Gloghini, Alessandra Viel, Daniela Gasparotto and Roberta Maestro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Mauro Boiocchi

117 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mauro Boiocchi Italy 38 2.4k 1.9k 1.5k 823 659 119 5.4k
Carlos E. Bacchi Brazil 37 2.2k 0.9× 1.6k 0.8× 932 0.6× 705 0.9× 569 0.9× 236 5.7k
Vallì De Re Italy 37 1.4k 0.6× 1.1k 0.6× 730 0.5× 1.3k 1.5× 591 0.9× 180 4.4k
M Boiocchi Italy 31 1.8k 0.8× 1.2k 0.7× 660 0.5× 214 0.3× 361 0.5× 94 3.3k
Bruno Rotoli Italy 42 1.2k 0.5× 564 0.3× 949 0.7× 374 0.5× 362 0.5× 185 5.5k
Αchilles Anagnostopoulos Greece 51 3.2k 1.4× 1.7k 0.9× 2.1k 1.5× 250 0.3× 465 0.7× 287 8.9k
S Poppema Netherlands 36 1.7k 0.7× 1.8k 1.0× 1.0k 0.7× 188 0.2× 152 0.2× 93 4.6k
Kiyohiko Hatake Japan 41 2.3k 1.0× 1.1k 0.6× 1.3k 0.9× 117 0.1× 225 0.3× 237 5.1k
Roberto Marasca Italy 35 1.8k 0.7× 1.2k 0.6× 771 0.5× 373 0.5× 173 0.3× 128 4.1k
Morio Koike Japan 40 1.9k 0.8× 621 0.3× 1.6k 1.1× 359 0.4× 1.6k 2.4× 128 6.6k
Woo Ick Yang South Korea 38 1.4k 0.6× 981 0.5× 1.8k 1.2× 102 0.1× 390 0.6× 221 5.0k

Countries citing papers authored by Mauro Boiocchi

Since Specialization
Citations

This map shows the geographic impact of Mauro Boiocchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Boiocchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Boiocchi more than expected).

Fields of papers citing papers by Mauro Boiocchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauro Boiocchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Boiocchi. The network helps show where Mauro Boiocchi may publish in the future.

Co-authorship network of co-authors of Mauro Boiocchi

This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Boiocchi. A scholar is included among the top collaborators of Mauro Boiocchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Boiocchi. Mauro Boiocchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pastrello, Chiara, Manuela Santarosa, Mara Fornasarig, et al.. (2005). MUC Gene Abnormalities in Sporadic and Hereditary Mucinous Colon Cancers with Microsatellite Instability. Disease Markers. 21(3). 121–126. 12 indexed citations
2.
Zancai, Paola, Jessica Dal Col, Sara Piccinin, et al.. (2005). Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins. Oncogene. 24(15). 2483–2494. 17 indexed citations
3.
Cecchin, Erika, Antonio Russo, Giuseppe Corona, et al.. (2004). UGT1A1*28 polymorphism in ovarian cancer patients. Oncology Reports. 12(2). 457–62. 23 indexed citations
4.
Toffoli, Giuseppe, et al.. (2004). Pharmacokinetic Optimisation of Treatment with Oral Etoposide. Clinical Pharmacokinetics. 43(7). 441–466. 68 indexed citations
5.
Libra, Massimo, Vallì De Re, Annunziata Gloghini, et al.. (2004). Second Primary Lymphoma or Recurrence: A Dilemma Solved by VDJ Rearrangement Analysis. Leukemia & lymphoma. 45(8). 1539–1543. 13 indexed citations
6.
Libra, Massimo, Roberto Sorio, Angela Buonadonna, et al.. (2003). Cisplatin may be a Valid Alternative Approach in Ovarian Carcinoma with Carboplatin Hypersensitivity. Report of Three Cases. Tumori Journal. 89(3). 311–313. 13 indexed citations
7.
Libra, Massimo, Vallì De Re, Daniela Gasparotto, et al.. (2002). Differentiation between non‐Hodgkin's lymphoma recurrence and second primary lymphoma by VDJ rearrangement analysis. British Journal of Haematology. 118(3). 809–812. 11 indexed citations
8.
Re, Vallì De, Salvatore De Vita, Daniela Gasparotto, et al.. (2002). Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. European Journal of Immunology. 32(3). 903–903. 77 indexed citations
9.
Toffoli, Giuseppe, et al.. (2001). Population pharmacokinetics and pharmacodynamics of oral etoposide. British Journal of Clinical Pharmacology. 52(5). 511–519. 50 indexed citations
10.
Dolcetti, Riccardo, Michele Quaia, Annunziata Gloghini, et al.. (1999). Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease. International Journal of Cancer. 80(2). 240–249. 12 indexed citations
11.
Corona, Giuseppe, Franca Giannini, Martina Fabris, Giuseppe Toffoli, & Mauro Boiocchi. (1998). Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cells. International Journal of Cancer. 75(1). 125–133. 55 indexed citations
12.
Toffoli, Giuseppe, et al.. (1997). Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells. International Journal of Cancer. 71(5). 900–906. 8 indexed citations
13.
Viel, Alessandra, Maurizio Genuardi, E Capozzi, et al.. (1997). Characterization ofMSH2 andMLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer. Genes Chromosomes and Cancer. 18(1). 8–18. 65 indexed citations
14.
Giannini, Franca, et al.. (1997). All-TRANS, 13-CIS and 9-CIS retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: Implications forin vivo retinoic acid use. International Journal of Cancer. 70(2). 194–200. 60 indexed citations
15.
Carbone, Antonino, Annunziata Gloghini, Rachele Volpe, Mauro Boiocchi, & Umberto Tirelli. (1994). High Frequency of Epstein-Barr Virus Latent Membrane Protein-1 Expression in Acquired Immunodeficiency Syndrome-related Ki-l (CD30)-positive Anaplastic Large-cell Lymphomas. American Journal of Clinical Pathology. 101(6). 768–772. 23 indexed citations
16.
Dolcetti, Riccardo, Claudio Doglioni, Roberta Maestro, et al.. (1992). p53 over‐expression is an early event in the development of human squamous‐cell carcinoma of the larynx: Genetic and prognostic implications. International Journal of Cancer. 52(2). 178–182. 130 indexed citations
17.
Boiocchi, Mauro & Giuseppe Toffoli. (1992). Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistance. European Journal of Cancer. 28(6-7). 1099–1105. 25 indexed citations
18.
Boiocchi, Mauro, Riccardo Dolcetti, Roberta Maestro, et al.. (1990). A coordinated proto-oncogene expression characterizes MCF 247 murine leukemia virus-induced T-cell lymphomas irrespectively of proviral insertion affecting myc loci. Leukemia Research. 14(6). 549–558. 7 indexed citations
19.
Carbone, Antonino, Annunziata Gloghini, Vallì De Re, et al.. (1990). Histopathologic, immunophenotypic, and genotypic analysis of Ki-1 anaplastic large cell lymphomas that express histiocyte-associated antigens. Cancer. 66(12). 2547–2556. 35 indexed citations
20.
Veronese, Silvio, et al.. (1987). Proliferative Activity in Human Urologic Malignancies: A Preliminary Study. Tumori Journal. 73(3). 295–299. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos E. Bacchi Breakdown of academic impact, for papers by Vallì De Re Breakdown of academic impact, for papers by M Boiocchi Breakdown of academic impact, for papers by Bruno Rotoli Breakdown of academic impact, for papers by Αchilles Anagnostopoulos Breakdown of academic impact, for papers by S Poppema Breakdown of academic impact, for papers by Kiyohiko Hatake Breakdown of academic impact, for papers by Roberto Marasca Breakdown of academic impact, for papers by Morio Koike Breakdown of academic impact, for papers by Woo Ick Yang
Rankless by CCL
2026